Preliminary Study of Letrozole Use for Improving Spermatogenesis in Non-obstructive Azoospermia Patients with Normal Serum FSH
Overview
Affiliations
We investigated whether letrozole (2.5 mg day(-1)) improves sperm count in non-obstructive azoospermia (NOA) patients. Four men were included in this study, and they had folliculo-stimulating hormone and other hormone levels within the normal range and no varicoceles or chromosomal aberrations. These four patients were administered letrozole for 3 months. Sperm count, testicular volume, gonadotropin, testosterone (T) and estradiol (E2) blood levels were assessed before, during and 1 week after the suspension of treatment. All patients showed spermatozoa in their ejaculate, increased gonadotropin and T levels and lower E2 levels (P<0.05 in all cases), when letrozole was administered. This suggests that letrozole treatment might improve sperm count in an NOA sub-population; however, more studies, including the proper controls, are needed to confirm its efficacy.
Adel O, El-Sherbiny H, Shahat A, Ismail S Vet Res Commun. 2024; 48(6):3941-3952.
PMID: 39382810 PMC: 11538146. DOI: 10.1007/s11259-024-10551-5.
Fadhil E, Mohammed M, Alkawaz U F1000Res. 2024; 12:1093.
PMID: 38957201 PMC: 11217721. DOI: 10.12688/f1000research.131985.3.
A Review on the Use of Letrozole in Female and Male Infertility.
Pajai S, Potdar J, Gopal U, Banait T Cureus. 2022; 14(11):e31291.
PMID: 36514610 PMC: 9733584. DOI: 10.7759/cureus.31291.
Hmood Jassim A, Abed A, Kareem Thamer A, Judi H, Enad A Arch Razi Inst. 2022; 77(1):367-373.
PMID: 35891754 PMC: 9288638. DOI: 10.22092/ARI.2021.356539.1864.
Tharakan T, Corona G, Foran D, Salonia A, Sofikitis N, Giwercman A Hum Reprod Update. 2022; 28(5):609-628.
PMID: 35526153 PMC: 9434299. DOI: 10.1093/humupd/dmac016.